Intech Investment Management LLC Reduces Stake in Humana Inc. $HUM

Key Points

• Intech Investment Management LLC significantly reduced its stake in Humana Inc. by 59.1%, now holding 14,811 shares valued at approximately $3.92 million.
• While several institutional investors have increased their holdings in Humana, the company has a high institutional ownership at 92.38%.
• Analysts have mixed opinions on Humana's stock, with a consensus rating of "Hold" and an average target price of $289.24, reflecting varying growth forecasts.

Intech Investment Management LLC decreased its position in Humana Inc. (NYSE:HUM - Free Report) by 59.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,811 shares of the insurance provider's stock after selling 21,361 shares during the quarter. Intech Investment Management LLC's holdings in Humana were worth $3,919,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Focus Partners Wealth increased its stake in shares of Humana by 104.2% in the first quarter. Focus Partners Wealth now owns 6,429 shares of the insurance provider's stock worth $1,701,000 after purchasing an additional 3,281 shares in the last quarter. Ransom Advisory Ltd bought a new position in shares of Humana in the first quarter valued at approximately $66,000. Glenview Trust co boosted its position in shares of Humana by 9.1% in the first quarter. Glenview Trust co now owns 40,478 shares of the insurance provider's stock valued at $10,710,000 after acquiring an additional 3,368 shares during the period. Bayforest Capital Ltd boosted its position in shares of Humana by 803.1% in the first quarter. Bayforest Capital Ltd now owns 4,416 shares of the insurance provider's stock valued at $1,168,000 after acquiring an additional 3,927 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Humana by 16.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,136,538 shares of the insurance provider's stock valued at $300,728,000 after purchasing an additional 158,528 shares in the last quarter. Institutional investors own 92.38% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the stock. Barclays lifted their price target on shares of Humana from $275.00 to $315.00 and gave the company an "equal weight" rating in a report on Friday, September 5th. Morgan Stanley dropped their target price on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating on the stock in a report on Thursday, July 31st. Robert W. Baird lowered their price target on Humana from $300.00 to $297.00 and set a "neutral" rating for the company in a research report on Friday, July 25th. Bank of America lifted their price target on Humana from $285.00 to $312.00 and gave the stock a "neutral" rating in a research report on Tuesday, September 2nd. Finally, Piper Sandler lowered their price target on Humana from $288.00 to $272.00 and set a "neutral" rating for the company in a research report on Thursday, July 31st. Seven investment analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Humana presently has an average rating of "Hold" and a consensus price target of $289.24.

Humana Stock Performance

Shares of NYSE HUM traded down $1.70 during midday trading on Monday, hitting $274.75. 1,271,657 shares of the company's stock traded hands, compared to its average volume of 1,618,744. The firm has a fifty day moving average of $266.10 and a 200 day moving average of $257.19. The stock has a market capitalization of $33.04 billion, a price-to-earnings ratio of 21.09, a price-to-earnings-growth ratio of 1.62 and a beta of 0.44. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $324.38. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). The business had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. On average, analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.3%. The ex-dividend date is Friday, September 26th. Humana's dividend payout ratio (DPR) is 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.